Growing community of inventors

Antibes, France

Yushma Bhurruth-Alcor

Average Co-Inventor Count = 3.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Yushma Bhurruth-AlcorGilles Ouvry (3 patents)Yushma Bhurruth-AlcorLaurence Clary (2 patents)Yushma Bhurruth-AlcorEtienne Thoreau (2 patents)Yushma Bhurruth-AlcorBranislav Musicki (2 patents)Yushma Bhurruth-AlcorJean-François Fournier (2 patents)Yushma Bhurruth-AlcorLoïc Tomas (2 patents)Yushma Bhurruth-AlcorCraig Steven Harris (1 patent)Yushma Bhurruth-AlcorMaryline Bourotte (2 patents)Yushma Bhurruth-AlcorBenoît Deprez (1 patent)Yushma Bhurruth-AlcorBranislav Musicki (1 patent)Yushma Bhurruth-AlcorYushma Bhurruth-Alcor (5 patents)Gilles OuvryGilles Ouvry (8 patents)Laurence ClaryLaurence Clary (37 patents)Etienne ThoreauEtienne Thoreau (19 patents)Branislav MusickiBranislav Musicki (14 patents)Jean-François FournierJean-François Fournier (2 patents)Loïc TomasLoïc Tomas (2 patents)Craig Steven HarrisCraig Steven Harris (14 patents)Maryline BourotteMaryline Bourotte (2 patents)Benoît DeprezBenoît Deprez (1 patent)Branislav MusickiBranislav Musicki (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Galderma Research & Development (5 from 222 patents)


5 patents:

1. 11731973 - Substituted pyrazolo[3,4-d]pyrimidines as mTOR inhibitors

2. 11518767 - MTOR inhibitor compounds

3. 10647706 - Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies

4. 10556883 - Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine and cosmetics

5. 10287278 - Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/5/2026
Loading…